ReviewCurrent allergy and asthma reports2019
Direct to Consumer Telemedicine.
Review in Current allergy and asthma reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 43 citations in OpenAlex.
- Article
- Identification and Management of Thyroid Dysfunction Using At-Home Sample Collection and Telehealth Services: Retrospective Analysis of Real-World Data.Journal of medical Internet research · 2023Article
- Direct-to-patient telehealth equity: Reaching diverse pediatric populations in primary care.Families, systems & health : the journal of collaborative family healthcare · 2023Article
- Using Telemedicine to Care for the Asthma Patient.Current allergy and asthma reports · 2022Review
- Providing Outpatient Telehealth Services in the United States: Before and During Coronavirus Disease 2019.Chest · 2021Review
- Telemedicine in Pediatric Infectious Diseases.Children (Basel, Switzerland) · 2021Review
- Digital Technologies and Data Science as Health Enablers: An Outline of Appealing Promises and Compelling Ethical, Legal, and Social Challenges.Frontiers in medicine · 2021Review
- Telemedicine Pays: Billing and Coding Update.Current allergy and asthma reports · 2020Review
- COVID-19: Pandemic Contingency Planning for the Allergy and Immunology Clinic.The journal of allergy and clinical immunology. In practice · 2020Review
- Telemedicine in the Era of COVID-19.The journal of allergy and clinical immunology. In practice · 2020Article
- Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?IEEE open journal of engineering in medicine and biology · 2020Article
- Home Virtual Visits for Outpatient Follow-Up Stroke Care: Cross-Sectional Study.Journal of medical Internet research · 2019Article
- Telehealth and Telemedicine in Missouri.Missouri medicineArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewTelemedicine uses technology to connect patients and data with providers at a distance. Direct to consumer telemedicine is a rapidly growing segment of the industry. RECENT
findingsThe telehealth market has skyrocketed in recent years, making it a multi-billion dollar industry. Direct to consumer telehealth, dominated by the for-profit private sector, is the most popular form. Direct to consumer telemedicine is a subset of telehealth that shows promise in increasing access to and engagement in medical care. Quality assurance, reimbursement, and regulatory oversight are important factors in assuring appropriate widespread adoption.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.